Cigna Group stock gains as Wells Fargo holds with USD 307 target
Published on 09/15/2026 at 15:42 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
The Cigna Group stock (ISIN US1255231003) traded at USD 290.05 on September 14, 2026, up 3.3 percent on the day and moving within a 52-week range between USD 239.51 and USD 315.47. According to GuruFocus on September 14, 2026, the shares have also shown a steady increase over the past month and year-to-date, leaving them about 8.1 percent below the 52-week high of USD 315.47.
Analyst view: Wells Fargo sticks to Hold
The most recent catalyst for Cigna Group stock comes from a fresh analyst update. As Futunn reported on September 15, 2026, Wells Fargo maintained its Hold rating on The Cigna Group and kept the price target at USD 307 per share. With the stock closing at USD 290.05 on September 14, 2026, this implies an upside potential of about 5.8 percent relative to the maintained target.
The cautious stance from Wells Fargo fits with valuation metrics highlighted by other analyses. According to GuruFocus, Cigna Group’s GF Score stands at 74 out of 100 and its GF Value estimate is USD 389.81 per share as of September 14, 2026, leaving the market price of USD 290.05 about 25.6 percent below that intrinsic value estimate.
Valuation, fundamentals and margins
The valuation gap between market price and GF Value gives investors a numerical sense of how analysts and quantitative models view the stock’s potential. On September 14, 2026, GuruFocus highlighted that The Cigna Group trades at USD 290.05 versus a GF Value of USD 389.81, suggesting a margin of safety of 25.6 percent under that model. The same analysis noted a GF Score of 74, which reflects above-average overall fundamentals in areas such as profitability, growth and financial strength.
Cigna’s business profile combines health insurance, pharmacy benefits and related services, where operating margins and scale are key. While the latest quarterly figures are not detailed in the week’s sources, the valuation metrics still hinge on an assessment of stable cash flows from its healthcare and pharmacy benefit management operations. As summarized by GuruFocus, the combination of a GF Score of 74 and the discount to GF Value points to solid fundamentals coupled with a share price that has not fully reflected them.
Risk factors and insider activity
For investors, risk is not only a matter of valuation but also of ownership signals. On September 14, 2026, GuruFocus pointed out that insider activity at The Cigna Group shows net selling of around USD 67.4 million over the past 12 months. This scale of net insider selling can be interpreted as a moderate risk signal, especially when contrasted with the modelled upside indicated by the GF Value estimate.
At the same time, the stock’s trading range gives a concrete sense of volatility. With a 52-week low of USD 239.51 and a high of USD 315.47, the September 14, 2026 closing price of USD 290.05 leaves the shares about 21.1 percent above the low and 8.1 percent below the high, based on data cited by GuruFocus. This range underscores that while the stock has recovered substantially from its lows, it is not yet at the top of its recent trading band.
Stock level and investor takeaway
As of the most recent completed trading day, September 14, 2026, The Cigna Group stock closed at USD 290.05 on the New York Stock Exchange, representing a 3.3 percent daily gain and sitting within roughly 8 percent of its 52-week high in USD terms, based on data referenced by GuruFocus. Against Wells Fargo’s maintained USD 307 price target, that closing level leaves a modest potential upside, while model-based valuation data suggest a larger theoretical gap to intrinsic value.
Key data on The Cigna Group stock
- Company: The Cigna Group Inc.
- ISIN: US1255231003
- Ticker: CI
- Trading venue: New York Stock Exchange
- Price (as of September 14, 2026): 290.05 USD
- Sector / Industry: Health Care / Managed Health Care
- Index membership: S&P 500
